PHENYLEPHRINE

PHENYLEPHRINE was reported 168111 times

PHENYLEPHRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL ARTERY STENT INSERTION 5 0.8333
1 FOETAL CARDIAC ARREST 4 0.2353
2 ANTERIOR SPINAL ARTERY SYNDROME 10 0.1190
3 FLOPPY IRIS SYNDROME 39 0.1057
4 SYNOVIAL FLUID ANALYSIS 8 0.0920
5 AQUEOUS FIBRIN 4 0.0784
6 TRIGEMINO-CARDIAC REFLEX 6 0.0741
7 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 4 0.0727
8 CORNEAL STRIAE 5 0.0704
9 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.0667
10 ERYTHROBLAST COUNT INCREASED 4 0.0667
11 MATERNAL EXPOSURE DURING DELIVERY 65 0.0656
12 TOXIC ANTERIOR SEGMENT SYNDROME 70 0.0642
13 HYPOTENSIVE TRANSFUSION REACTION 4 0.0606
14 CUTANEOUS MUCORMYCOSIS 11 0.0598
15 VASCULAR RESISTANCE SYSTEMIC DECREASED 8 0.0597
16 BURKHOLDERIA TEST POSITIVE 7 0.0565
17 FOETAL EXPOSURE DURING DELIVERY 33 0.0487
18 SUBRETINAL FIBROSIS 9 0.0462
19 SINUS RHYTHM 20 0.0459
20 POSTOPERATIVE DELIRIUM 9 0.0455
21 TOTAL LUNG CAPACITY INCREASED 12 0.0441
22 MEAN ARTERIAL PRESSURE DECREASED 11 0.0435
23 RETINAL CYST 7 0.0422
24 RENAL ISCHAEMIA 20 0.0366
25 EYE NAEVUS 4 0.0351
26 PITYRIASIS RUBRA PILARIS 8 0.0336
27 PARKINSONISM HYPERPYREXIA SYNDROME 6 0.0335
28 ALLERGIC TRANSFUSION REACTION 5 0.0331
29 CATARACT NUCLEAR 22 0.0330
30 PO2 INCREASED 16 0.0316
31 IRIDOCELE 4 0.0308
32 RETINAL DRUSEN 5 0.0305
33 DRY GANGRENE 19 0.0299
34 VITREAL CELLS 6 0.0297
35 CUTIS LAXA 8 0.0294
36 VENTILATION PERFUSION MISMATCH 8 0.0285
37 DERMATOCHALASIS 4 0.0272
38 CATARACT CORTICAL 4 0.0268
39 PCO2 INCREASED 19 0.0267
40 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 9 0.0259
41 VASOPLEGIA SYNDROME 42 0.0256
42 WRONG PRODUCT STORED 7 0.0246
43 RHYTHM IDIOVENTRICULAR 8 0.0246
44 HYPERDYNAMIC LEFT VENTRICLE 6 0.0244
45 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 12 0.0229
46 HYPERTENSIVE EMERGENCY 26 0.0221
47 BRADYCARDIA FOETAL 18 0.0217
48 PROCEDURAL HYPOTENSION 18 0.0212
49 MACULAR SCAR 4 0.0206
50 RETINAL ANEURYSM 4 0.0200
51 SYNOVIAL DISORDER 9 0.0198
52 RED BLOOD CELL SEDIMENTATION RATE DECREASED 5 0.0192
53 DIABETES INSIPIDUS 46 0.0191
54 RETINOGRAM ABNORMAL 5 0.0187
55 PROPOFOL INFUSION SYNDROME 13 0.0184
56 PRODUCT APPEARANCE CONFUSION 17 0.0184
57 DISTRIBUTIVE SHOCK 41 0.0181
58 DIABETIC RETINAL OEDEMA 9 0.0177
59 CHOROIDAL NEOVASCULARISATION 15 0.0175
60 TENOSYNOVITIS STENOSANS 9 0.0162
61 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 5 0.0161
62 CHOROIDITIS 6 0.0160
63 MACULAR FIBROSIS 10 0.0147
64 MACROGLOSSIA 8 0.0145
65 ANAESTHETIC COMPLICATION NEUROLOGICAL 13 0.0143
66 HYPOTONY OF EYE 6 0.0143
67 SCHIZOAFFECTIVE DISORDER 25 0.0140
68 CEREBRAL VASOCONSTRICTION 10 0.0135
69 PERINEAL ABSCESS 6 0.0133
70 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
71 VISUAL ACUITY REDUCED TRANSIENTLY 4 0.0130
72 PRODUCT PACKAGING CONFUSION 31 0.0128
73 FOETAL HEART RATE DECELERATION ABNORMALITY 9 0.0127
74 ANTERIOR CHAMBER CELL 9 0.0126
75 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
76 GENITAL ABSCESS 5 0.0124
77 UNWANTED AWARENESS DURING ANAESTHESIA 4 0.0122
78 BLOOD BICARBONATE DECREASED 23 0.0121
79 CANDIDA TEST POSITIVE 5 0.0120
80 BLOOD PH DECREASED 20 0.0117
81 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 10 0.0112
82 CONGESTIVE HEPATOPATHY 5 0.0112
83 HEPATIC ENZYME DECREASED 5 0.0111
84 NECROTISING COLITIS 14 0.0110
85 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
86 RETINAL SCAR 5 0.0108
87 NECROSIS ISCHAEMIC 5 0.0108
88 PSYCHOGENIC SEIZURE 10 0.0107
89 VITREOUS DETACHMENT 23 0.0106
90 SCROTAL ABSCESS 4 0.0106
91 CATARACT SUBCAPSULAR 6 0.0098
92 RETINAL ISCHAEMIA 6 0.0098
93 NORMAL NEWBORN 53 0.0097
94 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 10 0.0094
95 NECROTISING RETINITIS 6 0.0094
96 ENDOCRINE OPHTHALMOPATHY 8 0.0092
97 CYSTOID MACULAR OEDEMA 17 0.0090
98 STRESS CARDIOMYOPATHY 52 0.0089
99 PUPILS UNEQUAL 10 0.0087
100 LARYNGEAL STENOSIS 5 0.0087
101 FANCONI SYNDROME 12 0.0085
102 HYPOPYON 7 0.0085
103 TRYPTASE INCREASED 6 0.0084
104 PRIAPISM 29 0.0084
105 AMAUROSIS 7 0.0083
106 RESPIRATORY ACIDOSIS 32 0.0081
107 OXYGEN SATURATION ABNORMAL 23 0.0081
108 INTRAOCULAR LENS IMPLANT 4 0.0081
109 ISCHAEMIC HEPATITIS 11 0.0080
110 FOETAL HEART RATE DECREASED 5 0.0080
111 ALKALOSIS 3 0.0079
112 GLARE 4 0.0078
113 RETINAL INJURY 6 0.0078
114 CEREBELLAR INFARCTION 13 0.0077
115 CLONUS 21 0.0077
116 PULSELESS ELECTRICAL ACTIVITY 32 0.0077
117 RETINAL EXUDATES 7 0.0075
118 LIVE BIRTH 62 0.0074
119 HYPERTENSIVE URGENCY 4 0.0072
120 VITRITIS 13 0.0070
121 NODAL ARRHYTHMIA 6 0.0070
122 ELECTROENCEPHALOGRAM ABNORMAL 22 0.0070
123 PERIPHERAL ISCHAEMIA 28 0.0068
124 RETINAL TOXICITY 7 0.0068
125 CORNEAL OEDEMA 15 0.0067
126 SYSTOLIC DYSFUNCTION 7 0.0066
127 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 13 0.0066
128 VASOSPASM 6 0.0065
129 ARTERIOSPASM CORONARY 26 0.0065
130 PREMATURE DELIVERY 103 0.0065
131 ALLERGY TO CHEMICALS 8 0.0064
132 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
133 SUBRETINAL FLUID 7 0.0064
134 PUPIL FIXED 11 0.0063
135 PRODUCT LABEL CONFUSION 37 0.0063
136 DELAYED RECOVERY FROM ANAESTHESIA 6 0.0063
137 ANION GAP 4 0.0063
138 RETINAL OEDEMA 12 0.0063
139 RETINAL DEGENERATION 8 0.0062
140 PHAEOCHROMOCYTOMA 4 0.0061
141 DYSCHROMATOPSIA 5 0.0060
142 VITREOUS OPACITIES 5 0.0059
143 VASOCONSTRICTION 5 0.0057
144 OEDEMA MUCOSAL 6 0.0057
145 SCLERITIS 9 0.0056
146 PRODUCT NAME CONFUSION 6 0.0055
147 BRADYARRHYTHMIA 9 0.0055
148 CERUMEN IMPACTION 5 0.0055
149 METAMORPHOPSIA 10 0.0054
150 PUPILLARY REFLEX IMPAIRED 10 0.0054
151 VITREOUS FLOATERS 51 0.0052
152 SPINAL CORD INJURY 9 0.0052
153 EXTREMITY NECROSIS 9 0.0052
154 HAEMOPHILUS INFECTION 5 0.0051
155 GROIN ABSCESS 6 0.0051
156 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
157 ANTERIOR CHAMBER INFLAMMATION 3 0.0050
158 ENDOPHTHALMITIS 30 0.0050
159 RETINAL DISORDER 13 0.0050
160 MACULAR OEDEMA 28 0.0050
161 LOW BIRTH WEIGHT BABY 39 0.0049
162 METHAEMOGLOBINAEMIA 11 0.0047
163 ENTEROCOCCAL BACTERAEMIA 5 0.0047
164 NON-INFECTIOUS ENDOPHTHALMITIS 4 0.0047
165 VENTRICULAR HYPOKINESIA 15 0.0047
166 CARDIOGENIC SHOCK 67 0.0047
167 OCULAR HYPERTENSION 9 0.0046
168 HAEMODYNAMIC INSTABILITY 35 0.0046
169 GASTROINTESTINAL TOXICITY 22 0.0046
170 PRODUCT SELECTION ERROR 5 0.0046
171 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
172 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 15 0.0045
173 PERIRECTAL ABSCESS 5 0.0045
174 ANAESTHETIC COMPLICATION 12 0.0045
175 TACHYARRHYTHMIA 11 0.0044
176 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 6 0.0043
177 SCROTAL SWELLING 4 0.0043
178 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
179 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
180 CORNEAL DISORDER 9 0.0041
181 NODAL RHYTHM 6 0.0041
182 IDIOSYNCRATIC DRUG REACTION 4 0.0041
183 RHINITIS ALLERGIC 18 0.0040
184 PREMATURE BABY 121 0.0040
185 FACET JOINT SYNDROME 13 0.0040
186 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
187 DEAFNESS NEUROSENSORY 13 0.0039
188 RETINAL HAEMORRHAGE 28 0.0039
189 APGAR SCORE LOW 5 0.0039
190 CAPILLARY LEAK SYNDROME 8 0.0039
191 FOETAL DEATH 20 0.0039
192 PULSE ABSENT 18 0.0038
193 ISCHAEMIA 17 0.0037
194 PULMONARY ARTERIAL PRESSURE INCREASED 6 0.0037
195 OTITIS MEDIA 12 0.0036
196 PLEURITIC PAIN 10 0.0036
197 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 18 0.0035
198 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
199 C-REACTIVE PROTEIN ABNORMAL 22 0.0034
200 JAUNDICE CHOLESTATIC 12 0.0034
201 GENITAL PAIN 5 0.0034
202 CREPITATIONS 10 0.0034
203 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
204 X-RAY ABNORMAL 6 0.0034
205 ANAEMIA OF CHRONIC DISEASE 3 0.0033
206 HYPOMANIA 12 0.0033
207 VITREOUS HAEMORRHAGE 9 0.0033
208 HYPERTROPHIC CARDIOMYOPATHY 5 0.0032
209 SINUS ARREST 5 0.0032
210 ELECTROCARDIOGRAM T WAVE INVERSION 7 0.0032
211 ANGLE CLOSURE GLAUCOMA 8 0.0031
212 NECROTISING FASCIITIS 11 0.0031
213 PULMONARY TOXICITY 22 0.0031
214 BLADDER CATHETERISATION 3 0.0031
215 KOUNIS SYNDROME 7 0.0031
216 TONIC CLONIC MOVEMENTS 4 0.0031
217 RESPIRATORY ALKALOSIS 5 0.0031
218 DISLOCATION OF VERTEBRA 7 0.0031
219 HYPERAEMIA 6 0.0030
220 DEEP VEIN THROMBOSIS POSTOPERATIVE 6 0.0030
221 DUODENAL ULCER PERFORATION 22 0.0030
222 METABOLIC ACIDOSIS 94 0.0029
223 CORNEAL ABRASION 4 0.0029
224 RHEUMATOID NODULE 8 0.0029
225 TENOSYNOVITIS 8 0.0029
226 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
227 CATATONIA 15 0.0029
228 ACUTE PULMONARY OEDEMA 16 0.0028
229 BRADYCARDIA 150 0.0028
230 SEROTONIN SYNDROME 54 0.0028
231 CONJUNCTIVAL HYPERAEMIA 10 0.0028
232 HYPERPARATHYROIDISM SECONDARY 7 0.0028
233 PORPHYRIA ACUTE 4 0.0028
234 RESPIRATORY DEPRESSION 34 0.0028
235 SARCOIDOSIS 13 0.0027
236 GANGRENE 16 0.0027
237 SHOCK 61 0.0026
238 PREMATURE SEPARATION OF PLACENTA 4 0.0026
239 BRADYPNOEA 7 0.0026
240 NEPHROGENIC ANAEMIA 12 0.0026
241 CARDIOMYOPATHY 38 0.0026
242 BLOOD MAGNESIUM DECREASED 22 0.0025
243 VENTRICULAR FIBRILLATION 28 0.0025
244 SWOLLEN JOINT COUNT INCREASED 8 0.0025
245 CUSHINGOID 8 0.0025
246 MATERNAL EXPOSURE DURING PREGNANCY 221 0.0025
247 RHEUMATIC FEVER 11 0.0025
248 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
249 VENTRICULAR ARRHYTHMIA 9 0.0025
250 NASAL POLYPS 12 0.0024
251 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
252 SPINAL CORD DISORDER 4 0.0024
253 DRUG LEVEL INCREASED 40 0.0024
254 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 5 0.0024
255 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
256 CIRCULATORY COLLAPSE 41 0.0024
257 PHOTOPSIA 15 0.0024
258 DIABETIC RETINOPATHY 8 0.0024
259 ACIDOSIS 18 0.0024
260 RENAL TUBULAR NECROSIS 23 0.0023
261 MYDRIASIS 30 0.0023
262 HYPERCAPNIA 7 0.0023
263 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
264 STATUS EPILEPTICUS 26 0.0023
265 PROCEDURAL HAEMORRHAGE 9 0.0023
266 HYPOVOLAEMIC SHOCK 11 0.0023
267 ENCEPHALOPATHY 56 0.0023
268 FANCONI SYNDROME ACQUIRED 4 0.0023
269 HYPOTHERMIA 23 0.0023
270 HELICOBACTER INFECTION 23 0.0022
271 HYPERLACTACIDAEMIA 6 0.0022
272 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 16 0.0022
273 DRUG MONITORING PROCEDURE NOT PERFORMED 4 0.0022
274 BRONCHIECTASIS 15 0.0022
275 HYPOXIA 78 0.0022
276 LOBAR PNEUMONIA 4 0.0022
277 HEPATOTOXICITY 48 0.0022
278 EXPOSURE DURING PREGNANCY 133 0.0021
279 ACUTE RESPIRATORY FAILURE 40 0.0021
280 CARDIOPULMONARY FAILURE 8 0.0020
281 NASAL SEPTUM DEVIATION 4 0.0020
282 BLOOD CALCIUM DECREASED 23 0.0020
283 LACTIC ACIDOSIS 66 0.0020
284 MULTI-ORGAN DISORDER 4 0.0020
285 RETINAL TEAR 5 0.0020
286 APRAXIA 3 0.0020
287 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
288 INFUSION SITE REACTION 6 0.0020
289 INTESTINAL ISCHAEMIA 11 0.0020
290 CORONARY ARTERY THROMBOSIS 4 0.0020
291 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
292 PERIPHERAL VENOUS DISEASE 8 0.0020
293 SYNOVIAL CYST 9 0.0019
294 HYPOTENSION 388 0.0019
295 OLIGURIA 12 0.0019
296 WRONG PRODUCT ADMINISTERED 13 0.0019
297 TORSADE DE POINTES 15 0.0019
298 BLOOD LACTIC ACID INCREASED 10 0.0019
299 VISUAL ACUITY REDUCED 63 0.0019
300 BUNDLE BRANCH BLOCK LEFT 8 0.0019
301 EXOPHTHALMOS 4 0.0019
302 MITRAL VALVE INCOMPETENCE 21 0.0019
303 PLEURISY 11 0.0019
304 TROPONIN INCREASED 14 0.0018
305 CARDIAC ARREST 151 0.0018
306 HYPERVOLAEMIA 9 0.0018
307 INTENTIONAL OVERDOSE 115 0.0018
308 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
309 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
310 ATELECTASIS 17 0.0018
311 VENTRICULAR TACHYCARDIA 29 0.0018
312 PNEUMATOSIS INTESTINALIS 5 0.0018
313 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
314 ACUTE SINUSITIS 3 0.0017
315 FOETAL EXPOSURE DURING PREGNANCY 139 0.0017
316 AORTIC VALVE STENOSIS 3 0.0017
317 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
318 HAND DEFORMITY 22 0.0017
319 APNOEA 13 0.0017
320 ONYCHOMADESIS 7 0.0017
321 METABOLIC ENCEPHALOPATHY 5 0.0017
322 BURSITIS 20 0.0016
323 FOETAL GROWTH RESTRICTION 10 0.0016
324 COLITIS ISCHAEMIC 11 0.0016
325 FOLLICULITIS 17 0.0016
326 BRAIN DEATH 5 0.0016
327 CARDIAC MURMUR 14 0.0016
328 HYPERNATRAEMIA 8 0.0016
329 BLEPHAROSPASM 10 0.0016
330 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
331 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
332 RHEUMATOID FACTOR POSITIVE 9 0.0016
333 BREAST CANCER STAGE III 10 0.0015
334 MUCORMYCOSIS 4 0.0015
335 HAEMORRHAGE INTRACRANIAL 23 0.0015
336 HYPOVOLAEMIA 9 0.0015
337 ABDOMINAL WALL HAEMATOMA 3 0.0015
338 HYPOVENTILATION 5 0.0015
339 COMPARTMENT SYNDROME 4 0.0015
340 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
341 THERAPY NON-RESPONDER 68 0.0015
342 JOINT RANGE OF MOTION DECREASED 20 0.0015
343 NAIL DISORDER 13 0.0015
344 BLOOD SODIUM INCREASED 4 0.0015
345 SINUS TACHYCARDIA 21 0.0015
346 SEPTIC SHOCK 63 0.0014
347 TACHYPHRENIA 5 0.0014
348 HYPOPNOEA 5 0.0014
349 LUNG CONSOLIDATION 4 0.0014
350 ENDOTRACHEAL INTUBATION 4 0.0014
351 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
352 PREMATURE LABOUR 8 0.0014
353 BONE EROSION 5 0.0014
354 MYOCARDIAL ISCHAEMIA 16 0.0014
355 PRODUCT CONTAMINATION 5 0.0014
356 ACUTE HEPATIC FAILURE 19 0.0014
357 PULMONARY OEDEMA 61 0.0014
358 PEMPHIGUS 17 0.0014
359 PHYSICAL DISABILITY 6 0.0014
360 EJECTION FRACTION DECREASED 21 0.0013
361 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
362 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
363 BRAIN HERNIATION 4 0.0013
364 MUSCLE INJURY 11 0.0013
365 JOINT EFFUSION 9 0.0013
366 POST PROCEDURAL COMPLICATION 25 0.0013
367 DIASTOLIC DYSFUNCTION 4 0.0013
368 RESPIRATORY FAILURE 94 0.0013
369 TALIPES 4 0.0013
370 WOUND INFECTION 14 0.0013
371 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
372 BLEPHARITIS 5 0.0012
373 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
374 ANAPHYLACTOID REACTION 5 0.0012
375 RETINAL DETACHMENT 11 0.0012
376 BRONCHOSPASM 17 0.0012
377 BK VIRUS INFECTION 4 0.0012
378 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
379 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
380 TACHYCARDIA 105 0.0012
381 INTRAOCULAR PRESSURE INCREASED 15 0.0012
382 CANCER PAIN 3 0.0012
383 PNEUMONIA ASPIRATION 29 0.0012
384 HYPOALBUMINAEMIA 9 0.0012
385 ACUTE KIDNEY INJURY 177 0.0012
386 EYE INFLAMMATION 11 0.0012
387 HYPERTRANSAMINASAEMIA 8 0.0011
388 HYPERCHOLESTEROLAEMIA 11 0.0011
389 MACULOPATHY 4 0.0011
390 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
391 VISUAL FIELD DEFECT 8 0.0011
392 SHOCK HAEMORRHAGIC 9 0.0011
393 FEELING JITTERY 21 0.0011
394 MULTI-ORGAN FAILURE 19 0.0011
395 BRAIN INJURY 11 0.0011
396 HAEMOGLOBIN INCREASED 5 0.0011
397 ASTHMATIC CRISIS 4 0.0011
398 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
399 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
400 JOINT INJURY 23 0.0011
401 PERICARDITIS 18 0.0011
402 DEFORMITY 10 0.0011
403 SCHIZOPHRENIA 13 0.0011
404 HYPOGAMMAGLOBULINAEMIA 7 0.0011
405 PHOTOPHOBIA 20 0.0011
406 LEUKOCYTOSIS 19 0.0010
407 END STAGE RENAL DISEASE 19 0.0010
408 ATRIOVENTRICULAR BLOCK 8 0.0010
409 SINUS BRADYCARDIA 10 0.0010
410 FINGER DEFORMITY 5 0.0010
411 PRODUCT LABEL ISSUE 7 0.0010
412 ANAPHYLACTIC REACTION 57 0.0010
413 POST PROCEDURAL HAEMORRHAGE 12 0.0010
414 SPINAL OSTEOARTHRITIS 9 0.0010
415 INFARCTION 7 0.0010
416 ACUTE MYOCARDIAL INFARCTION 30 0.0010
417 DELIRIUM 35 0.0010
418 UNRESPONSIVE TO STIMULI 26 0.0010
419 LIP DRY 9 0.0010
420 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
421 LIVER INJURY 24 0.0010
422 MENTAL STATUS CHANGES 27 0.0010
423 PERIORBITAL OEDEMA 5 0.0010
424 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
425 BREAST CANCER STAGE II 8 0.0010
426 COAGULOPATHY 16 0.0010
427 FLANK PAIN 9 0.0010
428 FIBROMYALGIA 23 0.0009
429 ABSCESS LIMB 4 0.0009
430 ANAL ABSCESS 5 0.0009
431 AUTOIMMUNE DISORDER 9 0.0009
432 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
433 DRUG INTERACTION 145 0.0009
434 PROCEDURAL COMPLICATION 7 0.0009
435 ONYCHOMYCOSIS 4 0.0009
436 GRIP STRENGTH DECREASED 8 0.0009
437 CARDIAC FAILURE ACUTE 6 0.0009
438 HYPERTENSIVE CRISIS 10 0.0009
439 FLUID OVERLOAD 13 0.0009
440 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
441 TYPE 2 DIABETES MELLITUS 30 0.0009
442 ILEUS 11 0.0009
443 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
444 OBESITY 14 0.0009
445 TENDERNESS 9 0.0009
446 METABOLIC DISORDER 5 0.0009
447 CAESAREAN SECTION 10 0.0009
448 GLOSSODYNIA 19 0.0008
449 PROTHROMBIN TIME PROLONGED 5 0.0008
450 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
451 SUBCUTANEOUS ABSCESS 4 0.0008
452 KIDNEY TRANSPLANT REJECTION 4 0.0008
453 FAECAL INCONTINENCE 4 0.0008
454 SYNOVITIS 15 0.0008
455 BONE LESION 3 0.0008
456 THERAPEUTIC PRODUCT EFFECT DECREASED 37 0.0008
457 BLINDNESS TRANSIENT 6 0.0008
458 CARDIOMEGALY 10 0.0008
459 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
460 TACHYPNOEA 11 0.0008
461 RENAL INJURY 24 0.0008
462 TOXICITY TO VARIOUS AGENTS 136 0.0008
463 ANEURYSM 4 0.0008
464 INTESTINAL PERFORATION 9 0.0008
465 HYDRONEPHROSIS 6 0.0008
466 HYPERAMMONAEMIA 4 0.0008
467 COMA 38 0.0008
468 CYTOKINE RELEASE SYNDROME 16 0.0008
469 EYE PAIN 45 0.0008
470 LUNG INFILTRATION 7 0.0008
471 LIVER FUNCTION TEST INCREASED 17 0.0008
472 RENAL FAILURE CHRONIC 6 0.0008
473 BLOOD BILIRUBIN INCREASED 21 0.0008
474 HAEMOLYSIS 6 0.0008
475 ANAPHYLACTIC SHOCK 20 0.0008
476 PALLOR 21 0.0008
477 PULMONARY HYPERTENSION 16 0.0008
478 HEMIPARESIS 13 0.0008
479 NODULE 10 0.0008
480 RASH MACULO-PAPULAR 17 0.0008
481 JOINT STIFFNESS 20 0.0008
482 MACULAR DEGENERATION 9 0.0008
483 AZOTAEMIA 3 0.0008
484 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
485 IRRITABLE BOWEL SYNDROME 16 0.0007
486 RHINITIS 6 0.0007
487 CARDIO-RESPIRATORY ARREST 31 0.0007
488 NO THERAPEUTIC RESPONSE 9 0.0007
489 BLINDNESS 30 0.0007
490 PRODUCT PREPARATION ERROR 15 0.0007
491 EMBOLISM 6 0.0007
492 BLOOD PRESSURE DECREASED 48 0.0007
493 INTRACRANIAL PRESSURE INCREASED 4 0.0007
494 RIGHT VENTRICULAR FAILURE 5 0.0007
495 HYPERKALAEMIA 25 0.0007
496 BRAIN OEDEMA 9 0.0007
497 BLINDNESS UNILATERAL 10 0.0007
498 RENAL FAILURE ACUTE 30 0.0007
499 PRODUCT USE COMPLAINT 11 0.0007
500 CEREBRAL INFARCTION 17 0.0007
501 PANIC REACTION 5 0.0007
502 SCIATICA 11 0.0007
503 SUBARACHNOID HAEMORRHAGE 7 0.0007
504 MUSCULOSKELETAL PAIN 36 0.0007
505 EAR DISCOMFORT 7 0.0007
506 WOUND 19 0.0007
507 WHEEZING 40 0.0007
508 ATAXIA 8 0.0007
509 QUALITY OF LIFE DECREASED 9 0.0007
510 MYOCLONUS 8 0.0007
511 HYPERLIPIDAEMIA 8 0.0007
512 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
513 UVEITIS 9 0.0007
514 RENAL FAILURE 88 0.0007
515 SEIZURE 76 0.0007
516 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
517 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
518 ARTHRITIS INFECTIVE 3 0.0006
519 GENERALISED OEDEMA 8 0.0006
520 BACK INJURY 7 0.0006
521 PULMONARY HAEMORRHAGE 5 0.0006
522 FEAR 17 0.0006
523 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
524 SUBDURAL HAEMATOMA 9 0.0006
525 ATRIAL FLUTTER 5 0.0006
526 NEPHROPATHY TOXIC 7 0.0006
527 MIOSIS 5 0.0006
528 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
529 ARTHROPATHY 34 0.0006
530 POLYURIA 5 0.0006
531 SEPSIS 68 0.0006
532 IMPAIRED HEALING 20 0.0006
533 RENAL IMPAIRMENT 51 0.0006
534 WALKING AID USER 4 0.0006
535 ABDOMINAL TENDERNESS 3 0.0006
536 HEMIPLEGIA 5 0.0006
537 HAEMODIALYSIS 5 0.0006
538 TREATMENT FAILURE 49 0.0006
539 EYELID PTOSIS 6 0.0006
540 VISION BLURRED 81 0.0006
541 BACTERAEMIA 7 0.0006
542 MUSCLE RIGIDITY 7 0.0006
543 PSEUDOMONAS INFECTION 5 0.0006
544 SKIN ULCER 15 0.0006
545 RESPIRATORY DISTRESS 16 0.0006
546 HYPERBILIRUBINAEMIA 6 0.0006
547 CHRONIC KIDNEY DISEASE 44 0.0006
548 VENTRICULAR EXTRASYSTOLES 6 0.0006
549 EYE DISCHARGE 6 0.0006
550 C-REACTIVE PROTEIN INCREASED 21 0.0006
551 LARGE INTESTINE PERFORATION 4 0.0006
552 NEURALGIA 14 0.0006
553 RHABDOMYOLYSIS 24 0.0006
554 ACCIDENTAL OVERDOSE 21 0.0006
555 URINE OUTPUT DECREASED 5 0.0006
556 GROIN PAIN 5 0.0006
557 DIALYSIS 8 0.0006
558 SUICIDE ATTEMPT 34 0.0006
559 CARDIOTOXICITY 5 0.0006
560 ISCHAEMIC STROKE 10 0.0006
561 PARALYSIS 8 0.0006
562 HEPATIC ENZYME INCREASED 38 0.0006
563 DISABILITY 11 0.0006
564 ORAL DISORDER 4 0.0005
565 PNEUMONIA BACTERIAL 5 0.0005
566 ANGIOEDEMA 24 0.0005
567 HEART RATE DECREASED 19 0.0005
568 DRY EYE 27 0.0005
569 HAEMATOMA 14 0.0005
570 CONJUNCTIVITIS 10 0.0005
571 OCULAR DISCOMFORT 6 0.0005
572 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
573 ANHEDONIA 14 0.0005
574 CHROMATURIA 12 0.0005
575 HEPATIC FAILURE 16 0.0005
576 ECONOMIC PROBLEM 8 0.0005
577 POISONING DELIBERATE 5 0.0005
578 INJURY 37 0.0005
579 EYE HAEMORRHAGE 7 0.0005
580 RECALLED PRODUCT ADMINISTERED 5 0.0005
581 DRUG DISPENSING ERROR 8 0.0005
582 INFLAMMATION 27 0.0005
583 INTERCEPTED PRODUCT ADMINISTRATION ERROR 4 0.0005
584 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
585 HYPOGLYCAEMIA 25 0.0005
586 DRUG TOXICITY 7 0.0005
587 NEUROTOXICITY 9 0.0005
588 HAEMORRHAGIC STROKE 4 0.0005
589 DRUG INEFFECTIVE 673 0.0005
590 DRUG-INDUCED LIVER INJURY 16 0.0005
591 PLEURAL EFFUSION 31 0.0005
592 CYANOSIS 8 0.0005
593 CHOLECYSTITIS 6 0.0005
594 ULCER 8 0.0005
595 CEREBRAL HAEMORRHAGE 18 0.0005
596 HYPERTENSION 106 0.0005
597 TRANSAMINASES INCREASED 11 0.0005
598 ATRIAL FIBRILLATION 48 0.0005
599 MOTOR DYSFUNCTION 5 0.0005
600 LUNG DISORDER 24 0.0005
601 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
602 CHOLELITHIASIS 16 0.0005
603 CATARACT 29 0.0005
604 IMPAIRED QUALITY OF LIFE 7 0.0005
605 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
606 OCULAR HYPERAEMIA 23 0.0005
607 OXYGEN SATURATION DECREASED 27 0.0005
608 URINARY RETENTION 16 0.0005
609 BLOOD UREA INCREASED 8 0.0005
610 VISUAL IMPAIRMENT 59 0.0005
611 HYPOCALCAEMIA 9 0.0005
612 PSYCHOTIC DISORDER 14 0.0005
613 HAEMATEMESIS 12 0.0005
614 MUSCULOSKELETAL STIFFNESS 41 0.0005
615 IMPAIRED WORK ABILITY 10 0.0005
616 INFUSION RELATED REACTION 31 0.0005
617 SKIN HYPERPIGMENTATION 4 0.0005
618 PRESCRIBED OVERDOSE 9 0.0005
619 LACRIMATION INCREASED 14 0.0005
620 BLISTER 26 0.0005
621 RESPIRATORY TRACT INFECTION 12 0.0005
622 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
623 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
624 LUNG INFECTION 7 0.0005
625 NERVE INJURY 5 0.0004
626 WRONG DRUG ADMINISTERED 4 0.0004
627 MALNUTRITION 5 0.0004
628 MYOSITIS 4 0.0004
629 HYPERGLYCAEMIA 16 0.0004
630 GASTRIC HAEMORRHAGE 5 0.0004
631 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
632 EYELID OEDEMA 5 0.0004
633 THROMBOCYTOPENIA 48 0.0004
634 CONDITION AGGRAVATED 129 0.0004
635 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
636 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
637 PRODUCT PACKAGING ISSUE 4 0.0004
638 RED BLOOD CELL COUNT DECREASED 12 0.0004
639 EYE IRRITATION 24 0.0004
640 SWOLLEN TONGUE 13 0.0004
641 OVERDOSE 89 0.0004
642 ADRENAL INSUFFICIENCY 5 0.0004
643 NOCTURIA 5 0.0004
644 PRODUCT USE IN UNAPPROVED INDICATION 102 0.0004
645 DISCOMFORT 25 0.0004
646 CYTOPENIA 5 0.0004
647 ASCITES 12 0.0004
648 COELIAC DISEASE 4 0.0004
649 HYPERCALCAEMIA 5 0.0004
650 HYPOTONIA 4 0.0004
651 HAEMOGLOBIN DECREASED 41 0.0004
652 DYSARTHRIA 15 0.0004
653 TOXIC SKIN ERUPTION 4 0.0004
654 PRODUCT ADMINISTRATION ERROR 8 0.0004
655 MEDICATION ERROR 22 0.0004
656 OSTEOPENIA 6 0.0004
657 DRUG INTOLERANCE 38 0.0004
658 NEOPLASM MALIGNANT 26 0.0004
659 BLOOD CHOLESTEROL INCREASED 18 0.0004
660 PELVIC PAIN 7 0.0004
661 BONE DENSITY DECREASED 12 0.0004
662 RESTLESSNESS 14 0.0004
663 ROAD TRAFFIC ACCIDENT 16 0.0004
664 JOINT SWELLING 46 0.0004
665 ADVERSE REACTION 5 0.0004
666 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
667 INFECTION 54 0.0004
668 NIGHT SWEATS 12 0.0004
669 RESPIRATORY DISORDER 11 0.0004
670 PRODUCT DISPENSING ERROR 8 0.0004
671 PRODUCT PRESCRIBING ISSUE 8 0.0004
672 ABNORMAL FAECES 3 0.0004
673 ANXIETY 104 0.0004
674 LETHARGY 21 0.0004
675 PULMONARY FIBROSIS 7 0.0004
676 APHASIA 11 0.0004
677 SWELLING 34 0.0004
678 RESPIRATORY ARREST 10 0.0004
679 EAR PAIN 7 0.0004
680 HYPOMAGNESAEMIA 5 0.0004
681 COORDINATION ABNORMAL 5 0.0004
682 EYE PRURITUS 12 0.0004
683 DEVICE OCCLUSION 5 0.0004
684 HYPONATRAEMIA 20 0.0004
685 OSTEOARTHRITIS 15 0.0004
686 SINUS DISORDER 7 0.0004
687 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
688 SINUSITIS 36 0.0004
689 PRESCRIBED UNDERDOSE 7 0.0004
690 OEDEMA 19 0.0003
691 MUSCLE TWITCHING 8 0.0003
692 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
693 DIPLOPIA 9 0.0003
694 TASTE DISORDER 7 0.0003
695 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
696 PSORIATIC ARTHROPATHY 14 0.0003
697 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
698 SEDATION 9 0.0003
699 AGITATION 25 0.0003
700 COVID-19 PNEUMONIA 4 0.0003
701 BLOOD CREATININE INCREASED 22 0.0003
702 PULMONARY MASS 5 0.0003
703 LOSS OF CONSCIOUSNESS 43 0.0003
704 POLYNEUROPATHY 4 0.0003
705 ANAL INCONTINENCE 3 0.0003
706 GAIT INABILITY 11 0.0003
707 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
708 SMALL INTESTINAL OBSTRUCTION 4 0.0003
709 DEVICE RELATED INFECTION 5 0.0003
710 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
711 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
712 NECK PAIN 18 0.0003
713 HAEMATURIA 11 0.0003
714 OFF LABEL USE 281 0.0003
715 HEPATIC CIRRHOSIS 6 0.0003
716 ABDOMINAL PAIN LOWER 8 0.0003
717 LIVER DISORDER 14 0.0003
718 GASTRIC ULCER 6 0.0003
719 DISEASE RECURRENCE 15 0.0003
720 ERECTILE DYSFUNCTION 8 0.0003
721 GLAUCOMA 6 0.0003
722 HIATUS HERNIA 4 0.0003
723 DEEP VEIN THROMBOSIS 20 0.0003
724 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
725 URINARY INCONTINENCE 9 0.0003
726 ORAL CANDIDIASIS 4 0.0003
727 PULMONARY CONGESTION 4 0.0003
728 PERICARDIAL EFFUSION 7 0.0003
729 BLOOD PRESSURE ABNORMAL 6 0.0003
730 MUSCULAR WEAKNESS 34 0.0003
731 CONVULSION 17 0.0003
732 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
733 SINUS CONGESTION 4 0.0003
734 DRY MOUTH 24 0.0003
735 EPILEPSY 9 0.0003
736 SCAR 5 0.0003
737 LUNG NEOPLASM MALIGNANT 12 0.0003
738 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
739 UNEVALUABLE EVENT 22 0.0003
740 PNEUMONIA 94 0.0003
741 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
742 EMOTIONAL DISTRESS 35 0.0003
743 ABDOMINAL DISTENSION 30 0.0003
744 HYPERHIDROSIS 37 0.0003
745 CONFUSIONAL STATE 46 0.0003
746 TINNITUS 13 0.0003
747 LYMPHOCYTE COUNT DECREASED 5 0.0003
748 DRUG ERUPTION 5 0.0003
749 PRODUCT USE ISSUE 53 0.0003
750 RHEUMATOID ARTHRITIS 32 0.0003
751 HYPERTHYROIDISM 4 0.0003
752 BIPOLAR DISORDER 3 0.0003
753 HYPOKINESIA 4 0.0003
754 HYPERSENSITIVITY 51 0.0003
755 CARDIAC FAILURE 22 0.0003
756 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
757 HEPATITIS 7 0.0003
758 NEUTROPHIL COUNT DECREASED 11 0.0003
759 SLEEP DISORDER 19 0.0003
760 HEPATIC STEATOSIS 5 0.0003
761 SNEEZING 6 0.0003
762 BLOOD POTASSIUM DECREASED 8 0.0003
763 MOBILITY DECREASED 19 0.0003
764 ILL-DEFINED DISORDER 16 0.0003
765 LOWER LIMB FRACTURE 5 0.0003
766 RASH PRURITIC 14 0.0003
767 CELLULITIS 13 0.0003
768 DYSTONIA 5 0.0003
769 COGNITIVE DISORDER 12 0.0003
770 BALANCE DISORDER 22 0.0003
771 ARRHYTHMIA 12 0.0003
772 PERIPHERAL SWELLING 39 0.0003
773 PULMONARY EMBOLISM 24 0.0003
774 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
775 HAEMATOCRIT DECREASED 5 0.0003
776 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
777 ABDOMINAL DISCOMFORT 42 0.0003
778 PYREXIA 86 0.0002
779 MENTAL IMPAIRMENT 6 0.0002
780 MYOCARDIAL INFARCTION 43 0.0002
781 URTICARIA 41 0.0002
782 EYE DISORDER 8 0.0002
783 RIB FRACTURE 5 0.0002
784 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
785 PERITONITIS 5 0.0002
786 HEPATIC FUNCTION ABNORMAL 9 0.0002
787 EXPIRED PRODUCT ADMINISTERED 8 0.0002
788 DYSPNOEA 136 0.0002
789 SOMNOLENCE 48 0.0002
790 KNEE ARTHROPLASTY 5 0.0002
791 THROMBOSIS 19 0.0002
792 ANAEMIA 45 0.0002
793 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
794 DRUG RESISTANCE 6 0.0002
795 DEAFNESS 6 0.0002
796 ARTHRITIS 18 0.0002
797 PRODUCT QUALITY ISSUE 31 0.0002
798 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
799 PLATELET COUNT DECREASED 24 0.0002
800 STEVENS-JOHNSON SYNDROME 5 0.0002
801 NERVOUS SYSTEM DISORDER 7 0.0002
802 CARDIAC FAILURE CONGESTIVE 18 0.0002
803 ERYTHEMA 46 0.0002
804 THROAT IRRITATION 10 0.0002
805 FREQUENT BOWEL MOVEMENTS 6 0.0002
806 OEDEMA PERIPHERAL 27 0.0002
807 DYSKINESIA 9 0.0002
808 CHEST PAIN 41 0.0002
809 LIMB INJURY 6 0.0002
810 HAEMORRHAGE 23 0.0002
811 MIGRAINE 21 0.0002
812 RESTLESS LEGS SYNDROME 4 0.0002
813 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
814 INSOMNIA 58 0.0002
815 INTENTIONAL PRODUCT MISUSE 19 0.0002
816 HYPOKALAEMIA 10 0.0002
817 BLOOD GLUCOSE ABNORMAL 4 0.0002
818 PROCEDURAL PAIN 6 0.0002
819 AMNESIA 14 0.0002
820 SWELLING FACE 14 0.0002
821 VOMITING 101 0.0002
822 DEMENTIA 6 0.0002
823 STAPHYLOCOCCAL INFECTION 7 0.0002
824 COLITIS 8 0.0002
825 CHOLESTASIS 4 0.0002
826 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
827 ABDOMINAL PAIN 48 0.0002
828 LIVER FUNCTION TEST ABNORMAL 6 0.0002
829 CHOKING 4 0.0002
830 NASAL CONGESTION 12 0.0002
831 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
832 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
833 SYNCOPE 20 0.0002
834 PREGNANCY 4 0.0002
835 CORONARY ARTERY DISEASE 6 0.0002
836 THERAPEUTIC RESPONSE DECREASED 12 0.0002
837 STOMATITIS 12 0.0002
838 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
839 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
840 HYPOAESTHESIA 29 0.0002
841 HEART RATE INCREASED 19 0.0002
842 BRAIN FOG 3 0.0002
843 DYSURIA 7 0.0002
844 HALLUCINATION, VISUAL 4 0.0002
845 RASH ERYTHEMATOUS 9 0.0002
846 EAR INFECTION 5 0.0002
847 PAIN 114 0.0002
848 BLOOD POTASSIUM INCREASED 3 0.0002
849 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
850 BACK DISORDER 3 0.0002
851 NEUTROPENIA 25 0.0002
852 DYSPEPSIA 18 0.0002
853 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
854 COUGH 51 0.0002
855 COMPLETED SUICIDE 15 0.0002
856 CHILLS 21 0.0002
857 DYSPHAGIA 17 0.0002
858 PANCYTOPENIA 10 0.0002
859 CANDIDA INFECTION 3 0.0002
860 FLUSHING 18 0.0002
861 FLUID RETENTION 9 0.0002
862 BLOOD PRESSURE INCREASED 27 0.0002
863 CONTUSION 17 0.0002
864 PAIN IN EXTREMITY 52 0.0002
865 ANGINA PECTORIS 5 0.0002
866 DIZZINESS 87 0.0002
867 MUSCLE SPASMS 32 0.0002
868 NAUSEA 138 0.0002
869 SKIN DISCOLOURATION 8 0.0002
870 OROPHARYNGEAL PAIN 16 0.0002
871 HOT FLUSH 13 0.0002
872 DYSSTASIA 5 0.0002
873 CEREBROVASCULAR ACCIDENT 29 0.0002
874 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
875 URINARY TRACT INFECTION 29 0.0002
876 POLLAKIURIA 7 0.0002
877 PRODUCTIVE COUGH 8 0.0002
878 MEMORY IMPAIRMENT 23 0.0002
879 DIABETIC KETOACIDOSIS 4 0.0002
880 HEADACHE 104 0.0002
881 INTERSTITIAL LUNG DISEASE 8 0.0002
882 CRYING 6 0.0002
883 DEPRESSION 37 0.0002
884 BRONCHITIS 12 0.0002
885 GAIT DISTURBANCE 31 0.0002
886 EYE SWELLING 6 0.0002
887 LEUKOPENIA 8 0.0002
888 ASTHMA 18 0.0002
889 BLOOD SODIUM DECREASED 3 0.0002
890 PARAESTHESIA 25 0.0002
891 PRURITUS 61 0.0002
892 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
893 DEHYDRATION 21 0.0002
894 HYPOTHYROIDISM 5 0.0002
895 HYPOPHAGIA 4 0.0002
896 DRUG ABUSE 13 0.0002
897 BACK PAIN 36 0.0002
898 ARTHRALGIA 64 0.0002
899 RASH 67 0.0002
900 NERVOUSNESS 8 0.0002
901 SPEECH DISORDER 8 0.0002
902 NEPHROLITHIASIS 7 0.0002
903 NASOPHARYNGITIS 28 0.0002
904 DISORIENTATION 6 0.0002
905 PANCREATITIS 8 0.0002
906 FEBRILE NEUTROPENIA 10 0.0002
907 TREMOR 25 0.0002
908 ASTHENIA 56 0.0001
909 EXTRA DOSE ADMINISTERED 6 0.0001
910 TREATMENT NONCOMPLIANCE 8 0.0001
911 HALLUCINATION 11 0.0001
912 OSTEOPOROSIS 6 0.0001
913 PALPITATIONS 17 0.0001
914 GASTROINTESTINAL DISORDER 13 0.0001
915 FEELING COLD 4 0.0001
916 DISEASE PROGRESSION 17 0.0001
917 HAEMOPTYSIS 4 0.0001
918 WITHDRAWAL SYNDROME 6 0.0001
919 COVID-19 25 0.0001
920 PAIN IN JAW 4 0.0001
921 MENTAL DISORDER 6 0.0001
922 DECREASED APPETITE 32 0.0001
923 LABORATORY TEST ABNORMAL 4 0.0001
924 DIARRHOEA 87 0.0001
925 IRRITABILITY 8 0.0001
926 DIABETES MELLITUS 10 0.0001
927 ABDOMINAL PAIN UPPER 27 0.0001
928 FEELING HOT 8 0.0001
929 DRUG ADMINISTRATION ERROR 4 0.0001
930 DISTURBANCE IN ATTENTION 7 0.0001
931 EMOTIONAL DISORDER 4 0.0001
932 MALAISE 56 0.0001
933 ALOPECIA 25 0.0001
934 NO ADVERSE EVENT 23 0.0001
935 CYSTITIS 4 0.0001
936 BLOOD PRESSURE FLUCTUATION 3 0.0001
937 MOVEMENT DISORDER 4 0.0001
938 HIP FRACTURE 4 0.0001
939 RHINORRHOEA 8 0.0001
940 MYALGIA 21 0.0001
941 ADVERSE DRUG REACTION 11 0.0001
942 DYSGEUSIA 9 0.0001
943 LIP SWELLING 4 0.0001
944 GASTRIC DISORDER 4 0.0001
945 HYPOACUSIS 5 0.0001
946 WEIGHT DECREASED 32 0.0001
947 CONSTIPATION 25 0.0001
948 DRUG WITHDRAWAL SYNDROME 10 0.0001
949 FEELING ABNORMAL 27 0.0001
950 BLOOD GLUCOSE INCREASED 21 0.0001
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
952 INCORRECT DOSE ADMINISTERED 25 0.0001
953 FATIGUE 81 0.0001
954 DYSPHONIA 6 0.0001
955 ABNORMAL BEHAVIOUR 4 0.0001
956 ADVERSE EVENT 9 0.0001
957 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
958 DEPRESSED MOOD 5 0.0001
959 WEIGHT INCREASED 21 0.0001
960 RECTAL HAEMORRHAGE 4 0.0001
961 DRUG EFFECT DECREASED 5 0.0001
962 PRODUCT STORAGE ERROR 8 0.0001
963 CHEST DISCOMFORT 9 0.0001
964 INJECTION SITE REACTION 6 0.0001
965 PRODUCT SUBSTITUTION ISSUE 5 0.0001
966 SURGERY 5 0.0001
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
968 FALL 28 0.0001
969 BLOOD GLUCOSE DECREASED 4 0.0001
970 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
971 AGGRESSION 4 0.0001
972 HAEMATOCHEZIA 4 0.0001
973 THERAPY INTERRUPTED 5 0.0001
974 HERPES ZOSTER 4 0.0001
975 EPISTAXIS 5 0.0001
976 VERTIGO 4 0.0001
977 SUICIDAL IDEATION 6 0.0001
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
979 CARDIAC DISORDER 6 0.0001
980 DEATH 53 0.0001
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
982 UNDERDOSE 4 0.0001
983 PSORIASIS 7 0.0001
984 NEUROPATHY PERIPHERAL 5 0.0001
985 HOSPITALISATION 7 0.0000
986 DEVICE ISSUE 4 0.0000
987 PRODUCT DOSE OMISSION ISSUE 12 0.0000
988 ILLNESS 4 0.0000
989 DRY SKIN 5 0.0000
990 INFLUENZA 4 0.0000
991 INJECTION SITE ERYTHEMA 4 0.0000
992 DRUG DOSE OMISSION 5 0.0000